SEC Form 4 · accession 0000784199-18-000012
ARTIVION, INC. · AORT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott B Capps
Officer — VP, Clinical Research
Period of report
Feb 13, 2018
Accepted (ET)
Feb 15, 2018 · 5:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000784199
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 13, 2018 | F | 9,381 | $17.10 | D | 104,261 | D | |
| Common StockF2 | Feb 13, 2018 | M | 31,333 | $5.12 | A | 135,594 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F2 | $5.12 | Feb 13, 2018 | M | 31,333 | D | Feb 23, 2012 | Feb 23, 2018 | Common Stock | 31,333 | 0 | D |
Explanation of responses
- F1Payment of exercise by delivering shares in accordance to Rule 16b-3.
- F2Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/23/2012